Eligibility Prostate Cancer NCT00922129

Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
male patients ≤ 50 years in their post renal transplant follow-up;
Beskrivning

ID.1

Datatyp

boolean

biopsy confirmed prostate cancer;
Beskrivning

ID.2

Datatyp

boolean

stable renal function with gfr ≥ 40 ml/min.
Beskrivning

ID.3

Datatyp

boolean

Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with metastatic disease;
Beskrivning

ID.4

Datatyp

boolean

uncontrolled hyperlipidemia;
Beskrivning

ID.5

Datatyp

boolean

proteinuria > 500 mg/day;
Beskrivning

ID.6

Datatyp

boolean

biopsy evidence of acute rejection within the past 3 months;
Beskrivning

ID.7

Datatyp

boolean

existence of any surgical or medical condition, other than the current transplant, which in the opinion of the investigator might significantly alter the absorption, distribution, metabolism or excretion of study medication;
Beskrivning

ID.8

Datatyp

boolean

patients with mental illness;
Beskrivning

ID.9

Datatyp

boolean

inability to cooperate or communicate with the investigator or unable to complete self administered questionnaires.
Beskrivning

ID.10

Datatyp

boolean

Similar models

Eligibility Prostate Cancer NCT00922129

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
male patients ≤ 50 years in their post renal transplant follow-up;
boolean
ID.2
Item
biopsy confirmed prostate cancer;
boolean
ID.3
Item
stable renal function with gfr ≥ 40 ml/min.
boolean
Item Group
C0680251 (UMLS CUI)
ID.4
Item
patients with metastatic disease;
boolean
ID.5
Item
uncontrolled hyperlipidemia;
boolean
ID.6
Item
proteinuria > 500 mg/day;
boolean
ID.7
Item
biopsy evidence of acute rejection within the past 3 months;
boolean
ID.8
Item
existence of any surgical or medical condition, other than the current transplant, which in the opinion of the investigator might significantly alter the absorption, distribution, metabolism or excretion of study medication;
boolean
ID.9
Item
patients with mental illness;
boolean
ID.10
Item
inability to cooperate or communicate with the investigator or unable to complete self administered questionnaires.
boolean